Femostonconti 1 mg / 5 mg Norge - norsk - Statens legemiddelverk

femostonconti 1 mg / 5 mg

viatris healthcare ltd. - Østradiolhemihydrat / dydrogesteron - tablett, filmdrasjert - 1 mg / 5 mg

Desirett 75 mikrog Norge - norsk - Statens legemiddelverk

desirett 75 mikrog

exeltis healthcare s.l. (1) - desogestrel - tablett, filmdrasjert - 75 mikrog

Hydroxyzine Bluefish 25 mg Norge - norsk - Statens legemiddelverk

hydroxyzine bluefish 25 mg

bluefish pharmaceuticals ab - hydroksyzinhydroklorid - tablett, filmdrasjert - 25 mg

Hydroxyzine Bluefish 10 mg Norge - norsk - Statens legemiddelverk

hydroxyzine bluefish 10 mg

bluefish pharmaceuticals ab - hydroksyzinhydroklorid - tablett, filmdrasjert - 10 mg

Pantoprazol Pensa 20 mg Norge - norsk - Statens legemiddelverk

pantoprazol pensa 20 mg

pensa pharma ab - pantoprazolnatriumsesquihydrat - enterotablett - 20 mg

Pantoprazol Pensa 40 mg Norge - norsk - Statens legemiddelverk

pantoprazol pensa 40 mg

pensa pharma ab - pantoprazolnatriumsesquihydrat - enterotablett - 40 mg

Hypoloc Comp 5 mg / 12.5 mg Norge - norsk - Statens legemiddelverk

hypoloc comp 5 mg / 12.5 mg

menarini international o.l. sa - nebivololhydroklorid / hydroklortiazid - tablett, filmdrasjert - 5 mg / 12.5 mg

Takrolimus Accord 0.1 % Norge - norsk - Statens legemiddelverk

takrolimus accord 0.1 %

accord healthcare b.v. - takrolimusmonohydrat - salve - 0.1 %

Protopic Den europeiske union - norsk - EMA (European Medicines Agency)

protopic

leo pharma a/s - takrolimus - dermatitt, atopisk - andre dermatologiske preparater - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. forekommer fire ganger eller mer per år) som har hatt et første svar til maksimalt seks uker behandling av to ganger daglig takrolimus salve (lesjoner ryddet, nesten ryddet eller mildt rammet).

Takrozem 0.1 % Norge - norsk - Statens legemiddelverk

takrozem 0.1 %

pierre fabre dermatologie - takrolimus - salve - 0.1 %